Condensed Consolidated Statements 0f Stockholders’ Deficit (Unaudited) - USD ($)	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2019	$ 14	$ 206,569	$ 85,907,523	$ (89,036,271)	$ (2,922,165)
Balance (in Shares) at Dec. 31, 2019	13,602	206,569,062
Common stock issued on exercise of stock option and warrant		$ 25	1,725		1,750
Common stock issued on exercise of stock option and warrant (in Shares)		25,000
Stock-based compensation expense			439,956		439,956
Sale of common stock		$ 3,710	1,109,290		1,113,000
Sale of common stock (in Shares)		3,710,000
Net loss				(1,265,091)	(1,265,091)
Balance at Mar. 31, 2020	$ 14	$ 210,304	87,458,494	(90,301,362)	(2,632,550)
Balance (in Shares) at Mar. 31, 2020	13,602	210,304,062
Common stock issued on exercise of stock option and warrant		$ 1,050	72,450		73,500
Common stock issued on exercise of stock option and warrant (in Shares)		1,050,000
Stock-based compensation expense			344.430		344,430
Sale of common stock		$ 1,770	529,330		531,100
Sale of common stock (in Shares)		1,770,334
Net loss				(1,374,710)	(1,374,710)
Balance at Jun. 30, 2020	$ 14	$ 212,143	88,412,212	(91,676,072)	(3,051,703)
Balance (in Shares) at Jun. 30, 2020	13,602	212,143,146
RSA-based non-cash compensation		$ 19	6,508		6,527
RSA-based non-cash compensation (in Shares)		18,750
Cancelation of common stock		$ (1,000)	1,000
Cancelation of common stock (in Shares)		(1,000,000)
Balance at Dec. 31, 2020	$ 14	$ 190,529	93,778,591	(92,266,764)	1,702,370
Balance (in Shares) at Dec. 31, 2020	13,602	190,529,320
RSU restricted Stock		$ 31	4,519		4,550
RSU restricted Stock (in Shares)		31,250
Stock-based compensation			170,029		170,029
Common stock issued on exercise of stock option and warrant		$ 1,606	40,394		42,000
Common stock issued on exercise of stock option and warrant (in Shares)		1,605,682
Stock-based compensation expense		$ 158	47,340		47,499
Stock-based compensation expense (in Shares)		158,329
Sale of common stock		$ 7,056	2,250,944		2,258,000
Sale of common stock (in Shares)		7,056,250
Net loss				(1,086,438)	(1,086,438)
Balance at Mar. 31, 2021	$ 14	$ 199,381	96,291,817	(93,353,202)	3,138,010
Balance (in Shares) at Mar. 31, 2021	13,602	199,380,831
Balance at Dec. 31, 2020	$ 14	$ 190,529	93,778,591	(92,266,764)	1,702,370
Balance (in Shares) at Dec. 31, 2020	13,602	190,529,320
Balance at Jun. 30, 2021	$ 14	$ 200,090	96,638,926	(94,578,562)	2,260,468
Balance (in Shares) at Jun. 30, 2021	13,602	200,090,572
Balance at Mar. 31, 2021	$ 14	$ 199,381	96,291,817	(93,353,202)	3,138,010
Balance (in Shares) at Mar. 31, 2021	13,602	199,380,831
Stock-based compensation			318,818		318,818
Common stock issued on exercise of stock option and warrant		$ 710	28,290		29,000
Common stock issued on exercise of stock option and warrant (in Shares)		709,741
Sale of common stock				(1,225,360)	(1,225,360)
Sale of common stock (in Shares)
Balance at Jun. 30, 2021	$ 14	$ 200,090	$ 96,638,926	$ (94,578,562)	$ 2,260,468
Balance (in Shares) at Jun. 30, 2021	13,602	200,090,572